The 2024 US Microbiome Forum covers gut health and disease, as well as the stunning advances being made in understanding the gut-brain axis. Speakers will report on the developments in Probiotics, Prebiotics, and Postbiotic research as well as personalized nutrition and cardiometabolic disease. There is expanded coverage of Women’s health and, advances in HMO & infant health, Don’t forget we will explore the challenges and opportunities in translating research towards commercialization, as well as learn how partnerships and collaborations can secure investment.
I am delighted to confirm that Paul Carlson, Principal Investigator, Laboratory of Mucosal Pathogens and Cellular Immunology, CBER, FDA will be speaking about the regulatory considerations for microbiome-based therapeutics.
We will be running our very popular “flash” oral presentations for start-ups and any one giving a poster presentation.
The meeting is collocated with the 6th Skin Microbiome & Cosmeceuticals Congress: USA 2024.
Open Letter: Craig R. Cohen, MD, MPH
Professor, Department of Obstetrics, Gynaecology & Reproductive Sciences, University of California, San Francisco.
I am pleased to support the upcoming Microbiome R&D and Business Collaboration Congress in San Diego this October.
Advances in the last few years have provided a much deeper understanding of the complex and dynamic microbial communities that inhabit our bodies and impact our health. High-throughput sequencing and bioinformatics have facilitated more detailed and accurate analyses of microbial communities, revolutionizing our approach to microbiome research. We now know that the microbiome affects everything from mucosal and systemic immune function to mental health and chronic diseases.
Research has led to the creation of targeted live biotherapeutic products to optimize the vaginal microbiome to improve reproductive health outcomes. Yet completing the development process to receive FDA approval has proved challenging. However, clinical trials are taking place and are showing promise for the treatment of bacterial vaginosis and the prevention of preterm birth. In addition, clinical trials of live biotherapeutics have demonstrated efficacy to treat IBS, a range of skin conditions and improve infant health.
I’ll be giving the opening keynote on the potential of live biotherapeutic products to improve vaginal health. Bacterial vaginosis is a common issue with high recurrence rates, but a live biotherapeutic, Lactobacillus crispatus (LACTIN-V), is showing promise in reducing BV and inflammation associated with HIV susceptibility.
The advances are exciting, but we must continue studying these treatments to ensure long-term benefits. I look forward to our discussions at the congress on how we can accelerate the advancement of live biotherapeutics to improve reproductive health!
Best regards,
Craig R. Cohen, MD, MPH
80+ Speakers
7 ½ hours networking time
Vibrant Exhibition Hall
Attracting over 250 people the congress is designed to create a collaborative environment in which you can engage with the speakers, sponsors, and other delegations in attendance.
Learn how microbiome studies have since shed new light on Parkinson's Disease and how maternal bacterial metabolites may be important neurodevelopmental agents
Explore if the manipulation of skin microbial communities, including the use of pre- and probiotics, can maintain skin health and the Potential of LBPs to optimize the vaginal microbiome to improve reproductive health
| Date | Room 1 | Room 2 | Room 3 | Room 4 |
|---|---|---|---|---|
|
Day 1 - 17th October
|
Gut Health & Disease
|
Gut-Brain Axis
|
Infant Health, HMO & Nutrition
|
Skin Microbiome & cosmeceuticals
|
|
Day 2 - 18th October
|
Investment, Regulation and Manufacture
|
Urology and Women’s Health
|
Probiotics, Personalised Nutrition, & Cardiometabolic Diseases
|
Skin Microbiome & Cosmeceuticals
|
Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, presenting a poster is an excellent way to join the heart of this meeting.
Poster presentations are actively encouraged at this event and as such registered academic, industry, and start-up delegates are invited to present 1 poster each for free.
The agenda offers two sessions for multiple participants to deliver a Flash Oral Presentation of their posters. This platform is designed to amplify your research, providing a unique opportunity to present your findings to a dedicated audience of industry and academic leaders.
Submission deadline September 27.
Download the poster abstract submission form.
Sponsor a Global Engage meeting to access senior professionals in the life science industry and build your brand. Our events offer extensive networking opportunities, workshops, speaking positions, one-to-one delegate meetings, and exhibition booths to showcase your products and services. Gain a competitive advantage and position your company as a thought leader.
